These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37708385)

  • 1. Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease.
    Xiao Z; Lin Z; Xu L; Xu W; Huang H; Wang Y; Cao S; Xie Z; Liao W; Liao Y; Bin J; Feng W; Chen Y
    Eur J Prev Cardiol; 2023 Nov; 30(17):1924-1934. PubMed ID: 37708385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative remnant cholesterol exposure during young adulthood and middle age and risk of cardiovascular events: A 30-year population-based cohort study.
    Dai Y; Sheng Y; Zheng Z; Di W
    Int J Cardiol; 2024 Nov; 414():132435. PubMed ID: 39121920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.
    Quispe R; Martin SS; Michos ED; Lamba I; Blumenthal RS; Saeed A; Lima J; Puri R; Nomura S; Tsai M; Wilkins J; Ballantyne CM; Nicholls S; Jones SR; Elshazly MB
    Eur Heart J; 2021 Nov; 42(42):4324-4332. PubMed ID: 34293083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment.
    Delialis D; Georgiopoulos G; Aivalioti E; Mavraganis G; Dimopoulou AM; Sianis A; Aggelidakis L; Patras R; Petropoulos I; Ioannou S; Syrigou R; Chatzidou S; Kanakakis I; Stellos K; Stamatelopoulos K
    Hellenic J Cardiol; 2022; 66():26-31. PubMed ID: 35667617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between remnant cholesterol and incident atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation.
    Tada H; Kaneko H; Suzuki Y; Okada A; Takeda N; Fujiu K; Morita H; Ako J; Node K; Takeji Y; Takamura M; Yasunaga H; Komuro I
    J Clin Lipidol; 2024; 18(1):3-10. PubMed ID: 38061922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of low-density lipoprotein cholesterol/remnant cholesterol coordination on cardiovascular and cerebrovascular events in elderly patients with hypertension].
    Qu C; Qi SY; Li X; Gao H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Aug; 51(8):844-850. PubMed ID: 37583333
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data.
    Lindh M; Banefelt J; Fox KM; Hallberg S; Tai MH; Eriksson M; Villa G; Svensson MK; Qian Y
    Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):225-232. PubMed ID: 30649251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remnant cholesterol in atherosclerotic cardiovascular disease: A systematic review and meta-analysis.
    Delialis D; Georgiopoulos G; Aivalioti E; Konstantaki C; Oikonomou E; Bampatsias D; Mavraganis G; Vardavas C; Liberopoulos E; Stellos K; Stamatelopoulos K
    Hellenic J Cardiol; 2023; 74():48-57. PubMed ID: 37116829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental Benefit of Lipid Lowering in a Large Chinese Population Aged 75 Years and Older With Established Atherosclerotic Cardiovascular Disease.
    Lin Z; Chen Y; Xiao Z; Xu W; Chen G; Huang C; Feng W; Xie Z; Liao W; Liao Y; Bin J; Feng L; Wang S
    Mayo Clin Proc; 2023 Sep; 98(9):1280-1296. PubMed ID: 37661139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events.
    Zhang Y; Pletcher MJ; Vittinghoff E; Clemons AM; Jacobs DR; Allen NB; Alonso A; Bellows BK; Oelsner EC; Zeki Al Hazzouri A; Kazi DS; de Ferranti SD; Moran AE
    JAMA Cardiol; 2021 Dec; 6(12):1406-1413. PubMed ID: 34550307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative remnant cholesterol burden increases the risk of cardiovascular disease among young adults.
    Wang Y; Zhang Y; Wang X; Chen S; Tian X; Xu Q; Xia X; Wu S; Liu F; Wang A
    Ann Epidemiol; 2024 Jun; 94():127-136. PubMed ID: 38735386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remnant Cholesterol Predicts Risk of Cardiovascular Events in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.
    Gao S; Xu H; Ma W; Yuan J; Yu M
    J Am Heart Assoc; 2022 May; 11(10):e024366. PubMed ID: 35535621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of cumulative atherogenic index of plasma (AIP) for cardiovascular outcomes: a prospective community-based cohort study.
    Liu Z; Zhang L; Wang L; Li K; Fan F; Jia J; Li J; Zhang Y
    Cardiovasc Diabetol; 2024 Jul; 23(1):264. PubMed ID: 39026310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
    Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
    J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated remnant cholesterol and atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study.
    Wadström BN; Pedersen KM; Wulff AB; Nordestgaard BG
    Diabetologia; 2023 Dec; 66(12):2238-2249. PubMed ID: 37776347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Chevli PA; Islam T; Pokharel Y; Rodriguez F; Virani SS; Blaha MJ; Bertoni AG; Budoff M; Otvos JD; Shapiro MD
    J Clin Lipidol; 2022; 16(6):870-877. PubMed ID: 36180367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance Between Very Low-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort.
    Seehusen KE; Remaley AT; Sampson M; Meeusen JW; Larson NB; Decker PA; Killian JM; Takahashi PY; Roger VL; Manemann SM; Lam R; Bielinski SJ
    J Am Heart Assoc; 2024 Apr; 13(8):e031878. PubMed ID: 38591325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality.
    Doi T; Langsted A; Nordestgaard BG
    Atherosclerosis; 2023 Aug; 379():117141. PubMed ID: 37217436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.
    de Isla LP; Vallejo-Vaz AJ; Watts GF; Muñiz-Grijalvo O; Alonso R; Diaz-Diaz JL; Arroyo-Olivares R; Aguado R; Argueso R; Mauri M; Romero MJ; Álvarez-Baños P; Mañas D; Cepeda JM; Gonzalez-Bustos P; Casañas M; Michan A; Muñoz-Torrero JFS; Faedo C; Barba MA; Dieguez M; de Andrés R; Hernandez AM; Gonzalez-Estrada A; Padró T; Fuentes F; Badimon L; Mata P;
    Lancet Diabetes Endocrinol; 2024 Sep; 12(9):643-652. PubMed ID: 39098315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated lipoprotein(a) increases risk of subsequent major adverse cardiovascular events (MACE) and coronary revascularisation in incident ASCVD patients: A cohort study from the UK Biobank.
    Welsh P; Al Zabiby A; Byrne H; Benbow HR; Itani T; Farries G; Costa-Scharplatz M; Ferber P; Martin L; Brown R; Fonseca AF; Sattar N
    Atherosclerosis; 2024 Feb; 389():117437. PubMed ID: 38219651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.